Normalization of Serum Potassium With Sodium Zirconium Cyclosilicate (ZS-9) in Patients With Heart Failure

被引：1
|
作者：
Deedwania, Prakash [1 ]
Pina, Ileana L. [2 ]
Rasmussen, Henrik S. [3 ]
Lavin, Philip T. [4 ]
Singh, Bhupinder [3 ]
Yang, Alex [3 ]
McCullough, Peter A. [5 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Montefiore Med Ctr, Albert Einstein COM, Bronx, NY 10467 USA
[3] ZS Pharma Inc, Coppell, TX USA
[4] Boston Biostat Res Fdn, Framingham, MA USA
[5] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dallas, TX USA
来源：
JOURNAL OF CARDIAC FAILURE | 2015年 / 21卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2015.06.310
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
246
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [1] Sodium zirconium cyclosilicate (ZS-9) treatment in patients with serum potassium > 6.5 mEq/L
    Rasmussen, Henrik
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2015, 5 (04):
  • [2] Sodium zirconium cyclosilicate (ZS-9) treatment in patients with serum potassium > 6.5 mEq/L Response
    Karmacharya, Paras
    Poudel, Dilli R.
    Pathak, Ranjan
    Rettew, Andrew
    Alweis, Richard
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2015, 5 (04):
  • [3] Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia
    Rafique, Zubaid
    Peacock, William Frank
    LoVecchio, Frank
    Levy, Phillip D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (11) : 1727 - 1734
  • [4] Sodium Zirconium Cyclosilicate (ZS-9) in Chronic Kidney Disease Patients with Hyperkalemia
    Castner, Debra
    Singh, Bhupinder
    Menoyo, Jose
    Rasmussen, Henrik S.
    Gomez, Norma
    NEPHROLOGY NURSING JOURNAL, 2016, 43 (02) : 164 - 164
  • [5] Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia
    Packham, David K.
    Kosiborod, Mikhail
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (05) : 567 - 573
  • [6] Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia
    Linder, Kristin E.
    Krawczynski, Michelle A.
    Laskey, Dayne
    PHARMACOTHERAPY, 2016, 36 (08): : 923 - 933
  • [7] Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial
    Anker, Stefan D.
    Kosiborod, Mikhail
    Zannad, Faiez
    Pina, Ileana L.
    McCullough, Peter A.
    Filippatos, Gerasimos
    van der Meer, Peter
    Ponikowski, Piotr
    Rasmussen, Henrik S.
    Lavin, Philip T.
    Singh, Bhupinder
    Yang, Alex
    Deedwania, Prakash
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (10) : 1050 - 1056
  • [8] Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure
    Tardif, Jean-Claude
    Rouleau, Jean
    Chertow, Glenn M.
    Al-Shurbaji, Ayman
    Lisovskaja, Vera
    Gustavson, Stephanie
    Zhao, Yanli
    Bouabdallaoui, Nadia
    Desai, Akshay S.
    Chernyavskiy, Alexander
    Evsina, Maria
    Merkely, Bela
    McMurray, John J. V.
    Pfeffer, Marc A.
    ESC HEART FAILURE, 2023, 10 (02): : 1066 - 1076
  • [9] NORMALIZATION OF SERUM BICARBONATE WITH SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN THE PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED HARMONIZE STUDY
    de Francisco, Angel
    Rasmussen, Henrik
    Lavin, Philip
    Singh, Bhupinder
    Yang, Alex
    Mann, Johannes
    Jadoul, Michel
    Spinowitz, Bruce
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [10] SAFETY OF SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN HYPERKALEMIA: ANALYSIS OF GI EFFECTS IN THE PHASE 3 HARMONIZE STUDY
    Qunibi, Wajeh
    Kosiborod, Mikhail
    Rasmussen, Henrik S.
    Lavin, Philip T.
    Yang, Alex
    Lerma, Edgar
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A69 - A69
12345